FDA says knockoff versions of Lilly obesity drug must come off the market - The Associated Press

1. FDA says knockoff versions of Lilly obesity drug must come off the market  The Associated Press
2. FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next  Yahoo Finance
3. FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage  CNBC